DAVID GAUZE: Open Payments
NPI 1144572314 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 16 payments from 7 companies in 2025. Trend: 2023 $232 · 2024 $557 · 2025 $305
Food & beverage: $289Education: $16
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Calliditas Therapeutics US Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $42 |
| Novo Nordisk Inc | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
Products named: Kerendia, JYNARQUE, TARPEYO, JARDIANCE, Ozempic, RAYALDEE, LUPKYNIS.
Industry payments across KY — which companies pay providers there.
